Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.24B |
| 2 |
Apple
AAPL
|
+$1.14B |
| 3 |
Tesla
TSLA
|
+$1.05B |
| 4 |
Shopify
SHOP
|
+$1B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.13B |
| 2 |
Netflix
NFLX
|
+$1.1B |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.03B |
| 4 |
Eli Lilly
LLY
|
+$931M |
| 5 |
Trade Desk
TTD
|
+$899M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.77% |
| 2 | Communication Services | 17.54% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 7% |
| 5 | Financials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Xylem
XYL
$28.5B
| $27.4M | 0.02% |
185,500
-819
| -0.4% | -$114K |
|
302
iRhythm Holdings
IRTC
$4.09B
| $27M | 0.02% |
157,276
-140,216
| -47% | -$22.3M |
|
303
Targa Resources
TRGP
$55.8B
| $26.3M | 0.02% |
156,841
-889
| -0.6% | -$148K |
|
304
Cactus
WHD
$5.28B
| $26.1M | 0.02% |
660,421
+27,419
| +4% | +$1.15M |
|
305
Travere Therapeutics
TVTX
$5.83B
| $25.9M | 0.02% |
1,084,350
+312,828
| +41% | +$5.88M |
|
306
Chewy
CHWY
$9.84B
| $25.9M | 0.02% |
639,194
+88,028
| +16% | +$3.39M |
|
307
DT Midstream
DTM
$13.6B
| $25.7M | 0.02% |
227,332
-1,388
| -0.6% | -$145K |
|
308
Wolverine World Wide
WWW
$1.6B
| $25.7M | 0.01% |
935,665
-148,297
| -14% | -$3.9M |
|
309
Teledyne Technologies
TDY
$31.7B
| $25.5M | 0.01% |
43,583
+5,329
| +14% | +$2.92M |
|
|
ONC
310
BeOne Medicines Ltd
ONC
$34B
| $25.1M | 0.01% |
+73,598
| New | +$22.3M |
|
311
Mirion Technologies
MIR
$3.84B
| $24.5M | 0.01% |
1,051,494
-20,595
| -2% | -$445K |
|
312
Essent Group
ESNT
$6.12B
| $24.1M | 0.01% |
378,624
-562,718
| -60% | -$34.2M |
|
313
Alamos Gold
AGI
$13.1B
| $24M | 0.01% |
688,580
-101,945
| -13% | -$2.91M |
|
314
Utz Brands
UTZ
$1.25B
| $23.6M | 0.01% |
1,943,757
-60,908
| -3% | -$807K |
|
|
SLNO
315
DELISTED
Soleno Therapeutics
SLNO
| $23.6M | 0.01% |
+349,071
| New | +$25.9M |
|
|
UMH
316
UMH Properties
UMH
$1.3B
| $23.6M | 0.01% |
1,588,276
+51,914
| +3% | +$831K |
|
317
Crescent Energy
CRGY
$3.62B
| $23.1M | 0.01% |
2,593,998
-694,009
| -21% | -$6.3M |
|
318
Enterprise Products Partners
EPD
$81.6B
| $22.7M | 0.01% |
725,211
| – | – |
|
319
TotalEnergies
TTE
$188B
| $22.4M | 0.01% |
375,887
-30,947
| -8% | -$1.91M |
|
320
Atlantic Union Bankshares
AUB
$6.11B
| $22.3M | 0.01% |
632,579
-16,812
| -3% | -$572K |
|
321
Riskified
RSKD
$702M
| $22M | 0.01% |
4,709,854
-1,176,657
| -20% | -$5.79M |
|
322
Plains GP Holdings
PAGP
$4.97B
| $22M | 0.01% |
1,205,037
| – | – |
|
323
Century Communities
CCS
$2.03B
| $21.9M | 0.01% |
345,473
-135,002
| -28% | -$8.52M |
|
324
Coupang
CPNG
$28.7B
| $21.8M | 0.01% |
677,223
+617,563
| +1,035% | +$18.7M |
|
325
Credo Technology Group
CRDO
$41.8B
| $21.8M | 0.01% |
149,747
-391
| -0.3% | -$47.9K |
|
Similar funds
Jennison Associates's Q3 2025 Portfolio in Review
As of Q3 2025, Jennison Associates held 667 positions worth $172B, up 1.9% from $169B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Jennison Associates withdrew a net $8.14B in Q3 2025, closing 107 positions and reducing 253 holdings. Its most notable exit was Fair Isaac, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $627M.
- Jennison Associates's largest Q3 2025 buy was Advanced Micro Devices: 3,874,319 shares worth $627M.
- Jennison Associates added most to Oracle in Q3 2025, an estimated $2.24B increase.
- Jennison Associates's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.13B.
- Jennison Associates fully exited Fair Isaac in Q3 2025, selling an estimated $172M.
- Jennison Associates's ten largest holdings make up 47% of its $172B portfolio in Q3 2025.
- Jennison Associates opened 93 new positions and closed 107 in Q3 2025.
- Jennison Associates's portfolio value rose 1.9% quarter-over-quarter to $172B.
Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.